AZD 8081
Latest Information Update: 19 Feb 2007
At a glance
- Originator AstraZeneca
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Gastrointestinal disorders
Most Recent Events
- 07 Jul 2006 This compound is still in active development for functional gastrointestinal disease (AstraZeneca development pipeline 2006)
- 02 Mar 2005 Preclinical trials in Gastrointestinal disorders in Europe (unspecified route)